摘要
本文详细阐述了叶酸的体内的生物学作用,影响体内叶酸的因素及与脑卒中的关系,说明了叶酸对人体健康的重要性及预防脑卒中的意义。为有效预防脑卒中,人们应该多摄入富含叶酸的食物或服用含叶酸维生素,尤其是患有H型高血压的人群,以补足人体所需的叶酸。
This article stated the biological effects of folic acid in human body in detail,discussed influencing factors of folic acid level in human body and the relationship between folic acid and stroke,and illustrated the significance of folic acid for human health and prevention of stroke.People,especially patients with H-type hypertention should ingest foods rich in folic acid or take multivitamin containing folic acid to meet the demand of human body and to prevent stroke effectively.
引文
[1] Mitchell HK, Snell EE, Williams RJ. The concentration of "folic acid"[J].J Am Chem Soc, 1941,63(8) :2284．
[2] M. Klerk, P. Verhoef, R. Clarke, et al. MTHFR Studies Collaboration Group, MTHFR 677C>T polymorphism and risk of coronary heart disease: a meta-analysis[J]. J. Am. Med. Assoc,2003,(288) :2023-2031．
[3] 韩明勇,刘以伟.叶酸生物学作用的研究[J].化工劳动保护,1997,18(6) :264-265．
[4] 陈青川,牟世芬.叶酸的需要量研究[J].国外医学卫生学分册,1996,23(6) :345-347．
[5] 李红,张连富.叶酸的生理功能及其强化[J].山西食品工业,1999,1:1-2．
[6] Selhub J. Folate, vitamin B12 and vitamin B6 and one carbon metabolism[J]. J Nutr Health Aging,2002,6(1) :39-42．
[7] Allen, L. H. Causes of vitamin B_(12) and folate deficiency[J]. Food Nutr Bull 2008,29:S20-34; discussion S35-27．
[8] Sarah C. Tinker, Mary E. Cogswell, Owen Devine. Folic Acid Intake Among U.S. WomenAged 15~44 Years, National Health and Nutrition Examination Survey, 2003-2006[J]. Am J Prev Med,2010,38(5) :534-542．
[9] Monika Eichholzer, Otmar T?nz, Roland Zimmermann. Folic acid: a public-health challenge[J]. Lancet,2006,22(367) :1352-1361
[10] Jacob Seihub, Paul F. Jacques, Irwin H. Serum Total Homocysteine Concentrations in the Third National Health and Nutrition Examination Survey (1991-1994) : Population Reference Ranges and Contribution of Vitamin Status to High Serum Concentrations[J].Ann Intern Med, 1999,131:331-333．
[11] Pfeiffer CM, Johnson CL, Jain RB, et al. Trends in blood folate and vitamin B12 concentrations in the United States, 1988-2004[J]. Am J Clin Nutr,2007,86(3) :528-530．
[12] 郝玲,郑俊池,田熠华,等.血浆叶酸两种常用检测方法检测结果的比较[J].北京大学学报(医学版),2004,36(2) :210-214
[13] 郝玲,田熠华,谭明.我国部分地区35～64岁人群血浆叶酸水平与年龄性别差异比较[J].营养学报,2002,24(4) :352-356．
[14] 汪国海,霍勇,王梦德,等.中国六城市轻中度高血压患者血清叶酸水平的调查[J].卫生研究,2007,36(3) :305-307．
[15] Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase[J].Nat Genet.1995,10(1) :111-113．
[16] Clark ZE, Bowen DJ, Whatley SD, et al. Genotyping method for methylenetetrahydrofolate reductase (C677T thermolabile variant)using heteroduplex technology[J]. Clin Chem,1998,44:2360-2362．
[17] Hiraoka, M., K. Kato, et al. Gene-nutrient and gene-gene interactions of controlled folate intake by Japanese women. Biochem Biophys Res Commun,2004,316(4) :1210-1216．
[18] 项青云,霍勇,王梦德,等.不同性别原发性高血压患者血清叶酸甘油三酯与水平MTHFR C677T位点的相关性[J].安徽医科大学学报,2007,42(1) :54-58．
[19] 李勇,郭静萱,陈大方.亚甲基四氢叶酸还原酶基因多态性与心肌梗死的相关研究[J].中华心血管病杂志,2000,28(2) :114-116．
[20] 王林,郭宏,李玉明.原发性高血压患者MTHFR基因C 677 T多态性及血浆Hcy水平的变化[J].天津医药,2002,30(10) :579-582．
[21] Ashfield-Watt, P. A?C. H. Pullin, et al. Methylenetetrahydrofolate reductase 677C?T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial[J]. Am J Clin Nutr,2002,76(1) :180-186．
[22] Devlin, A. M., R. Clarke, et al. Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population[J]. Am J Clin Nutr,2006,83(3) :708-713．
[23] Mansoor MA, Kristensen O, Herving T, et al. Low concentrations of folate in serum and erythrocytes of smokers: methionine loading decreases folate concentrations in serum of smokers and nonsmokers[J]. Clin Chem,1997,43:2192-2194．
[24] Piyathilake CJ, Macaluso M, Hine RJ, et al. Local and systemic effects of cigarette smoking on folate and vitamin B12[J]. Am J Clin Nutr,1994,60:559-66．
[25] Cafolla a, F Dragoni, G. Girelli. Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomised controlled trial in Italian smoker-blood donors[J].Atherosclerosis,2002,(163) :105-111．
[26] Constantine I Vardavas, Manolis K Linardakis, Christos M Hatzis. Smoking status in relation to serum folate and dietary vitamin intake[J]. Tobacco Induced Diseases,2008,4:8．
[27] Giovannucci E. Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies[J]. J Nutr,2004,134:2475-2481．
[28] Mason JB, Choi SW. Effects of alcohol on folate metabolism:implications for carcinogenesis[J].Alcohol,2005,35:235-241．
[29] Giovannucci E. Alcohol, one-carbon metabolism, and colorectal cancer: recent insights from molecular studies[J]. J Nutr,2004,134:2475-81．
[30] A.Gibson, J.V.Woodside, I.S.Young. Alcohol increases homocysteine and reduces B vitamin concentration in healthy male volunteers-a randomized, crossover intervention study[J]. Q J Med,2008,101:881-887．
[31] Bogdan Cylwik, Lech Chrostek, Marta Daniluk. Relationship between plasma Folate and Homocysteine Concentration in Alcoholics According to liver Enzyme Activity[J]. J Nutr Sci Vitaminol,2009,55:439-441．
[32] Idem. The effect of oral contraceptives on folate metabolism[J]. Am J Obstet Gynecol, 1971,11:782-79．
[33] A. Majid Shojania. Oral contraceptives: effects on folate and vitamin B12 metabolism[J]. CMA JOURNAL, 1982,126:244-247．
[34] G. Franklin Carl, Farlyn Z, Hudson et al. Phenytoin-Induced Depletion of Folate in Rats Originates in Liver and Involves a Mechanism That Does Not Discriminate Folate Form[J]. American Society for Nutritional Sciences, 1997,2231-2238．
[35] Frank M. Faraci; Steven R. Hyperhomocysteinemia, Oxidative Stress, and Cerebral Vascular Dysfunction[J]. Stroke,2004,35,345-347．
[36] Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project[J]. JAMA, 1997,277: 1775-1781．
[37] Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis[J].BMJ,2002,325:1201-1206．
[38] Moghaddasi, M, M. Mamarabadi, et al. Homocysteine, vitamin B_(12) and folate levels in Iranian patients with ischemic stroke[J]. Neurol Res,2010,32(9) :953-956．
[39] Yang Q, Botto LD, Erickson JD, et al. Improvement in stroke mortality in Cananda and the United States[J], 1999 to 2002． Circulation,2006,113:1335-1343．
[40] Mark SD, Wang W, Fraumeni JF, et al. Lowered risks of hypertension and cerebrovascular disease after vitamine/mineral supplementation: the Linxian nutrition intervenetion[J]. Am J Epidemiol, 1996,143:658-664．
[41] Wang X, Qin X, Demartas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis[J].Lancet,2007,369:1876-1882．
[42] Larsson, S. C, S. Mannisto, et al. Folate, vitamin B6, vitamin B12, and methionine intakes and risk of stroke subtypes in male smokers[J]. Am J Epidemiol 2008,167(8) : 954-961．
[43] Cui, R., H. Iso, et al. Dietary Folate and Vitamin B6 and B12 Intake in Relation to Mortality From Cardiovascular Diseases[J]. Japan Collaborative Cohort Study. Stroke,2010,41(6) :1285-1289
[44] Terwecoren, A., E. Steen, et al. Ischemic stroke and hyperhomocysteinemia: truth or myth?[J]. Acta Neurol Belg,2009,109(3) :181-188．
[45] Zhao D, Liu J, Wang W, et al. Epidemiolongical transition of strokein China twenty-one-year observational study from the Sino-MONICA-Beijingproject[J].Stroke,2008,39:1668-1674．
[46] 王拥军,刘力生,饶克勤,等.我国脑卒中预防策略思考:同时控制 高血压和高同型半胱氨酸水平[J].中华医学杂志,2008,88(47) :3316-3318．
[47] 胡大一,徐希平.有效控制“H型”高血压-预防脑卒中的新思路[J].中华内科杂志,2008,47(12) :976-977．
[48] 李建平,霍勇,刘平,等.马来酸依那普利叶酸片降压,降同型半胱氨酸的疗效和安全性[J].北京大学学报(医学版),2007,39,614-618．
[49] Grahma, IM, Daly LE ,Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease[J]. The Europena Concerted Action Project. JAMA,1997,277:1775-1781．
[50] HOPE-2． .Lonn E, Yusuf S, Arnold MJ, et al . Homocysteines lowering with folic acid and B vitamins in vascular disease[J]. N EngJ Med,2006,354:1567-1577．
[51] Zoungas S, McGrath BP, Branley P, et al. Cardiovascular morbididity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial(ASFAST)in chronic renal failure: a multicenter, randomized,controlled trial[J]. J Am Coll Cardiol,2006,47:l 108-1116．
